
Treatment GuideJust DiagnosedSex & DatingAfrican AmericanStigmaAsk the HIV DocPrEP En EspañolNewsVoicesPrint IssueVideoOut 100
CONTACTCAREER OPPORTUNITIESADVERTISE WITH USPRIVACY POLICYPRIVACY PREFERENCESTERMS OF USELEGAL NOTICE
© 2023 Pride Publishing Inc.
All Rights reserved
All Rights reserved
By continuing to use our site, you agree to our Private Policy and Terms of Use.
A double dose of a commonly used vaccine is more effective at preventing hepatitis B infection among HIV-positive adults than the standard single dose, researchers from Brazil report in the journal Vaccine. Nearly half of the study subjects given a double vaccine dose posted significant increases in hepatitis B'specific antibodies, compared to 34% of those given a single dose. Double dosing is particularly effective for HIV patients with CD4-cell counts above 350 and HIV viral loads below 10,000. __________ It might be possible to safely stop anti'hepatitis C drugs after just half the recommended course of treatment, researchers report in The New England Journal of Medicine. Patients who have no detectable blood-based levels of hepatitis C virus after 12 weeks of Peg-Intron and Rebetol treatment can stop at that point instead of at the standard 24-week mark, Italian researchers say. Drug side effects also were significantly lower in patients who stopped HCV therapy early. __________ Sexual transmission of hepatitis C virus among HIV-positive gay men in Paris was shown to be linked with sex acts that can lead to bleeding in the anus, including unprotected anal intercourse, rough anal intercourse, and such practices as fisting, according to a study in the June edition of Eurosurveillance Monthly. Mucosal lesions associated with other sexually transmitted diseases that can lead to anal bleeding also can boost HCV infection risks, researchers report. __________ Adults coinfected with HIV and hepatitis C who have high baseline levels of a key liver enzyme and low levels of a liver protein are at a higher risk of experiencing hepatitis-related liver toxicity while taking anti-HIV medications, researchers report in the July edition of the Journal of Viral Hepatitis. High pretreatment aspartate aminotransferase and low albumin levels are linked with abnormally elevated liver enzyme levels and eventual liver damage, according to the study of 85 coinfected adults. __________ French researchers report in the June issue of the Journal of Hepatology that liver disease is now a top cause of death among adults coinfected with HIV and hepatitis. A study of the records of coinfected patients who died in 2000 in France showed that 31% of deaths among HIV-HCV coinfected patients was linked to liver disease, with 29% of deaths tied to AIDS-related complications. Twenty-two percent of HIV-HBV coinfected patients who died were killed by liver disease. Although triple coinfection with HIV, HCV, and HBV was rare, these patients were at the highest risk of death from liver disease.
DON'T MISS THE OUT100 SPECIAL 3 DAY MARATHON STARTING NOVEMBER 24TH!
Journey through the year’s influential Out100 – the most iconic and long-standing celebration of LGBTQ+ icons and allies – in a 1-hour television special spotlighting the LGBTQ+ people shaping the world today.
WATCH & LIVESTREAM ON ADVOCATECHANNEL.COM
AND ON THE ADVOCATE CHANNEL APP
Download the Advocate Channel App for your mobile phone and your favorite streaming device!
From our Sponsors
Most Popular
Plus: Featured Video
Latest Stories
7 Uplifting Films To Celebrate Trans Awareness Week & Where To Stream Them
November 17 2023 10:25 AM
Out's Deal Guide: Grab Your 50% Off Amazon Fire Tablets & More Recommended Deals on Amazon Today!
November 03 2023 3:44 PM
Unlock Massive Savings at 'The Holiday Shop': Amazon's Hottest Deals of the Season Await!
November 02 2023 2:17 PM
Dianne Feinstein’s Commitment to People Living With HIV Won’t Be Forgotten
November 02 2023 1:27 PM
PEPFAR in Peril: The Far-Right Wants to End the Lifesaving Global HIV Program
October 24 2023 1:52 PM
Plus Nov/Dec Issue: PEPFAR in Danger & Our Allies and Advocates of the Year
October 23 2023 11:53 AM
Trending stories
Most Recent
Recommended Stories for You
HIV Plus Editors
Editor
Ryan is the Digital Director of The Advocate Channel, and a graduate of NYU Tisch's Department of Dramatic Writing. She is also a member of GALECA, the LGBTQ+ society of entertainment critics. While her specialties are television writing and comedy, Ryan is a young member of the LGBTQ+ community passionate about politics and advocating for all.
Ryan is the Digital Director of The Advocate Channel, and a graduate of NYU Tisch's Department of Dramatic Writing. She is also a member of GALECA, the LGBTQ+ society of entertainment critics. While her specialties are television writing and comedy, Ryan is a young member of the LGBTQ+ community passionate about politics and advocating for all.